Stanley J. Cryz

Immunotheraphy and vaccines / edited by Stanley J. Cryz (1990)

Cryz, Stanley J

Incluye bibliografía e índice

Expanded Safety and Immunogenicity of a Bivalent, Oral, Attenuated Cholera Vaccine, CVD 103-HgR Plus CVD 111, in United States Military Personnel Stationed in Panama

Taylor, David N., Sanchez, José L., Castro, José M., Lebron, Carlos, Parrado, Carlos M., Johnson, David E., ...

To provide optimum protection against classical and El Tor biotypes of Vibrio cholerae O1, a single-dose, oral cholera vaccine was developed by combining two live, attenuated vaccine strains, CVD...

Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

Tacket, Carol O., Cohen, Mitchell B., Wasserman, Steven S., Losonsky, Genevieve, Livio, Sofie, Kotloff, Karen, ...

CVD 103-HgR is a live oral cholera vaccine strain constructed by deleting 94% of the gene for the enzymatically active A subunit of cholera toxin from classical Inaba Vibrio cholerae O1 569B; the...

Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria

Viret, Jean-Francois, Favre, Didier, Wegmüller, Bernhard, Herzog, Christian, Que, John U., Cryz, Stanley J., ...

The mucosal and systemic immune responses after primary and booster immunizations with two attenuated live oral vaccine strains derived from a noninvasive (Vibrio cholerae) and an invasive...

Immunochemical Studies of Diphtherial Toxin and Related Nontoxic Mutant Proteins

Cryz, Stanley J., Welkos, Susan L., Holmes, Randall K.

Competitive binding radioimmunoassays were used to analyze the immunochemistry of diphtherial toxin. Rabbit antisera obtained by immunization with formolized toxoid or fragment A were used to...

Expanded Safety and Immunogenicity of a Bivalent, Oral, Attenuated Cholera Vaccine, CVD 103-HgR Plus CVD 111, in United States Military Personnel Stationed in Panama

Taylor, David N., Sanchez, José L., Castro, José M., Lebron, Carlos, Parrado, Carlos M., Johnson, David E., ...

To provide optimum protection against classical and El Tor biotypes of Vibrio cholerae O1, a single-dose, oral cholera vaccine was developed by combining two live, attenuated vaccine strains, CVD...

Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

Tacket, Carol O., Cohen, Mitchell B., Wasserman, Steven S., Losonsky, Genevieve, Livio, Sofie, Kotloff, Karen, ...

CVD 103-HgR is a live oral cholera vaccine strain constructed by deleting 94% of the gene for the enzymatically active A subunit of cholera toxin from classical Inaba Vibrio cholerae O1 569B; the...

Mucosal and Systemic Immune Responses in Humans after Primary and Booster Immunizations with Orally Administered Invasive and Noninvasive Live Attenuated Bacteria

Viret, Jean-Francois, Favre, Didier, Wegmüller, Bernhard, Herzog, Christian, Que, John U., Cryz, Stanley J., ...

The mucosal and systemic immune responses after primary and booster immunizations with two attenuated live oral vaccine strains derived from a noninvasive (Vibrio cholerae) and an invasive...

Immunochemical Studies of Diphtherial Toxin and Related Nontoxic Mutant Proteins

Cryz, Stanley J., Welkos, Susan L., Holmes, Randall K.

Competitive binding radioimmunoassays were used to analyze the immunochemistry of diphtherial toxin. Rabbit antisera obtained by immunization with formolized toxoid or fragment A were used to...